口服安托补充剂对体内神经发生,依赖海马的认知和基于血液的痴呆症生物标志物的影响:在患有痴呆症的老年人中进行24周随机对照试验的结果
Chiara de Lucia1,2,3, Diego Alejandro Tovar-Rios1,4,5,6, Khadija Khalifa1,7
1Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Armauer Hansens vei 30, 4011 Stavanger, Norway.
Nutrients
|August 28, 2025
概括
补充安托素对大脑细胞生长和认知有积极影响, 有助于预防痴呆. 血液中的生物标记与神经发生相关,有助于个性化治疗策略.
科学领域:
- 神经科学
- 生物化学
- 老年学
背景情况:
- 神经保护和定位神经生成对于预防痴呆症至关重要.
- 氨酸是一种植物性化合物,
研究的目的:
- 调查素补充剂对海马前细胞的影响.
- 探索基于血液的痴呆症生物标志物与体外神经生成之间的关系.
- 确定个性化痴呆症预防策略的潜在调节者.
主要方法:
- 一个24周的随机,双盲,安慰剂对照试验的二次分析.
- 用来自试验参与者的血清治疗海马前代细胞.
- 与临床和血液生物标志物数据一起分析细胞变化.
主要成果:
- 素补充会影响海马前代细胞和认知.
- 血液痴呆症生物标志物与人体体内神经生成标志物之间的相关性.
- 身体质量指数 (BMI) 和ApoE4载体状态被确定为调节效应.
结论:
- 对神经保护和痴呆症的预防有希望.
- 基于血液的生物标志物可用于临床试验丰富和个性化.
- 需要进一步的研究来阐明素机制,并优化治疗中生物标志物的使用.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
Cognitive Development During Adulthood
255
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
255
Aging
179
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
179
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260


